Business Context and Reporting Period
This Form 8-K was filed by Heatwurx, Inc. (not Processa Pharmaceuticals, Inc.) on August 6, 2015, reporting an event that occurred on August 1, 2015. The company is incorporated in Delaware and maintains its principal executive offices in Gardena, California.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance changes.
Material Changes
On August 1, 2015, Reginald Greenslade resigned from his position as a director of the Company. The filing explicitly states that there were no disagreements between Mr. Greenslade and the Company regarding operations, policies, or practices.
Guidance, Outlook, and Risks
The filing contains no management commentary, financial guidance, outlook, or discussion of risks and contingencies beyond the director resignation.
Investor Verification Checklist
- Verify the identity of the registrant (Heatwurx, Inc.) versus the requested company name (Processa Pharmaceuticals, Inc.).
- Confirm the effective date of Reginald Greenslade's resignation (August 1, 2015).
- Check for any subsequent filings regarding the appointment of a replacement director.